Allografting or autografting for myeloma. [N Engl J Med. 2007] - PubMed Result

Search for

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: N Engl J Med. 2007 Jun 21;356(25):2646-8; author reply 2646-8.Links

Comment on:: N Engl J Med. 2007 Mar 15;356(11):1110-20.

Allografting or autografting for myeloma.

van Rhee F, Crowley J, Barlogie B.

PMID: 17582078 [PubMed - indexed for MEDLINE]

Related Articles

Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation. [Haematologica. 2005]
Allografting or autografting for myeloma. [N Engl J Med. 2007]
Bortezomib with or without dexamethasone in relapsed multiple myeloma following allogeneic hematopoietic cell transplantation. [Haematologica. 2006]
A comparison of allografting with autografting for newly diagnosed myeloma. [N Engl J Med. 2007]
[Current therapy for multiple myeloma] [Pol Arch Med Wewn. 2005]
» See all Related Articles...

Patient Drug Information

Bortezomib (Velcade®) Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with at least one other medication. Bortezomib is also used to treat people with mantle cell ly...

» read more ...

Display Show